Skip to main content
Premium Trial:

Request an Annual Quote

Pangea Releases Latest Version Of GeneWorld

Premium

OAKLAND, Calif.--Pangea Systems has released GeneWorld 3.5, an upgraded version of its sequence analysis and annotation software package. New features will further enable researchers to accelerate gene discovery and "take the next step towards elucidating a gene's function," the company claimed. Pangea said an advanced pipeline architecture lets users "create strategies that function on multiple sequences, as well as strategies with sequence annotation and masking components."

Using Pangea's Unified Life Science Environment application programming interface, the company said its customers can extend GeneWorld to operate with existing bioinformatics systems and solutions developed in-house or purchased from third-party vendors.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.